Precigen Inc Stock Ownership - Who owns Precigen?

Insider buying vs selling

Have Precigen Inc insiders been buying or selling?
Nancy H. AgeeDirector2024-07-0517,605$1.42
Donald P. LehrChief Legal Officer2024-04-0555,075$1.40
Rutul R. ShahChief Operating Officer2024-04-0540,870$1.40
Harry Thomasian Jr.Chief Financial Officer2024-04-0567,389$1.40
Jeffrey Thomas PerezSVP IP Affairs2024-04-0544,199$1.40
Helen SabzevariPresident and CEO2024-04-05410,357$1.40
James S. TurleyDirector2024-03-1443,706$1.43
Randal J. KirkDirector2024-03-1469,930$1.43
Steven FrankDirector2024-03-1434,965$1.43
Vinita D. GuptaDirector2024-03-1444,055$1.43

1 of 5

PGEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PGEN insiders and whales buy or sell their stock.

PGEN Shareholders

What type of owners hold Precigen Inc stock?
Randal J. Kirk60.18%151,903,969$233.93MInsider
Trading Sa Ares8.18%20,647,152$31.80MInsider
Patient Capital Management LLC6.91%17,453,455$26.88MInstitution
Blackrock Inc4.11%10,363,128$15.96MInstitution
Vanguard Group Inc2.68%6,768,234$10.42MInstitution
Geode Capital Management LLC1.20%3,030,885$4.67MInstitution
State Street Corp1.12%2,825,450$4.35MInstitution
Helen Sabzevari0.88%2,221,076$3.42MInsider
Iridian Asset Management LLC0.83%2,091,274$3.22MInstitution
D E Shaw Co Inc0.71%1,784,886$2.75MInstitution

1 of 3

PGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PGEN24.42%72.43%Net BuyingNet Buying
KYTX57.89%42.11%Net BuyingNet Buying
AURA78.91%17.52%Net Buying
AVXL37.61%4.89%Net BuyingNet Buying

Precigen Stock Ownership FAQ

Who owns Precigen?

Precigen (NASDAQ: PGEN) is owned by 24.42% institutional shareholders, 72.43% Precigen insiders, and 3.15% retail investors. Randal J. Kirk is the largest individual Precigen shareholder, owning 151.90M shares representing 60.18% of the company. Randal J. Kirk's Precigen shares are currently valued at $249.12M.

If you're new to stock investing, here's how to buy Precigen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.